Zum Hauptinhalt springen

Cannabis als Rauschmittel

08. Mai 2025 | Cannabis als Rauschmittel

Association of recreational cannabis legalization with changes in medical, illegal, and total cannabis expenditures in Canada.

Association of recreational cannabis legalization with changes in medical, illegal, and total cannabis expenditures in Canada. McDonald AJ, Cooper A, Doggett A, Halladay J, Belisario K, MacKillop J. Int J Drug Policy. 2025 Apr 5;139:10…

08. Mai 2025 | Cannabis als Rauschmittel

Effects of legal access versus illegal market cannabis on use and mental health: A randomized controlled trial.

Effects of legal access versus illegal market cannabis on use and mental health: A randomized controlled trial. Baltes-Flueckiger L, Steinauer R, Meyer M, Guessoum A, Herrmann O, Mosandl CF, et al. Addiction. 20…

08. Mai 2025 | Cannabis als Rauschmittel

Cannabis Use and Misuse Following Recreational Cannabis Legalization.

Cannabis Use and Misuse Following Recreational Cannabis Legalization. McDonald AJ, Doggett A, Belisario K, Gillard J, De Jesus J, Vandehei E, Lee L, Halladay J, MacKillop J. JAMA Netw Open. 2025 Apr 1;8(4):e256551. doi: 10.1001/jamanet…

20. April 2025 | Cannabis als Rauschmittel

Convergence of Cannabis and Psychosis on the Dopamine System.

Convergence of Cannabis and Psychosis on the Dopamine System. Ahrens J, Ford SD, Schaefer B, et al. JAMA Psychiatry. Published online April 09, 2025. doi:10.1001/jamapsychiatry.2025.0432 https://jamanetwork.com/journals…

18. April 2025 | Cannabis als Rauschmittel

Does Cannabis Use Contribute to Schizophrenia? A Causation Analysis Based on Epidemiological Evidence.

Does Cannabis Use Contribute to Schizophrenia? A Causation Analysis Based on Epidemiological Evidence. Pourebrahim S, Ahmad T, Rottmann E, Schulze J, Scheller B. Biomolecules. 2025 Mar 4;15(3):368. doi: 10.3390/biom15030368. PMID: 4014…

18. April 2025 | Cannabis als Rauschmittel

The Pharmacology of Cannabinoids in Chronic Pain.

The Pharmacology of Cannabinoids in Chronic Pain. Cortez-Resendiz A, Leiter TJ, Riela SM, Graziane NM, Raup-Konsavage WM, Vrana KE. Med Cannabis Cannabinoids. 2025 Feb 5;8(1):31-46. doi: 10.1159/000543813. PMID: 40046175; PMCID: PMC118…

18. April 2025 | Cannabis als Rauschmittel

Cannabinoid Hyperemesis Syndrome: A Rising Complication.

Cannabinoid Hyperemesis Syndrome: A Rising Complication. Peles S, Khalife R, Magliocco A. Cureus. 2025 Feb 13;17(2):e78958. doi: 10.7759/cureus.78958. PMID: 40091958; PMCID: PMC11910202. https://pmc.ncbi.nlm.nih.gov/articles/PMC11910202/

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten